The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform
Open accessAbstract
Rationale: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection. Objective: This study examined whether human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy. Methods and Results: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferonβ1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferonβ1 treatment. Conclusions: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, using patient-specific hiPSC-CMs, researchers are able to model various CVDs such as long QT syndrome, LV non-compaction, hypertrophic cardiomyopathy and dilated cardiomyopathy [217,423,424].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [424]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Sudden Deaths in Young Competitive Athletes
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
Claycomb, W. C., Lanson, N. A., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., & Izzo, N. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2979 · Cited by 1,546
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325
Tohyama, S., Hattori, F., Sano, M., Hishiki, T., Nagahata, Y., Matsuura, T., Hashimoto, H., Suzuki, T., Yamashita, H., Satoh, Y., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.09.013 · Cited by 1,045
Feldman, A. M., & McNamara, D. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 954
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 823
Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Lundy, S. D., Zhu, W.-Z., Regnier, M., & Laflamme, M. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0490 · Cited by 738
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1002/rmv.326 · DOI
Cited by
Sorted by citations
Items 101–148 of 148
El‐Aziz, A. M. A., Serag, E., Kenawy, M. Y., El‐Maghraby, A., & Kandil, S. H. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1170097 · Cited by 9
Intensive care for human hearts in pluripotent stem cell models
Golforoush, P. A., & Schneider, M. D. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-0090-7 · Cited by 8
Yahia, S., Dena, A. S. A., Nashar, R. M. E., & El-sherbiny, I. M. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00818a · Cited by 9
Monnerat, G., Kasai-Brunswick, T. H., Asensi, K. D., dos Santos, D. S., Barbosa, R. A. Q., Mesquita, F., Albuquerque, J. P. C., Ferreira, R., Wendt, C., de Miranda, K. R., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1007418 · Cited by 9
Screening-Based Chemical Approaches to Unravel Stem Cell Biology
Chen, S. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.012 · Cited by 8
Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice
Jiang, Y., Zhu, R., Luo, L., Mu, Q., Zhu, Y., Luo, H., Zou, X., & Shen, X. (2015) · Intervirology · doi:10.1159/000442588 · Cited by 7
Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy
Panda, A., Gurusamy, N., Rajasingh, S., Carter, H.-K., Thomas, E. L., & Rajasingh, J. (2020) · Differentiation · doi:10.1016/j.diff.2019.12.001 · Cited by 8
Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity
Wang, P.-H., Fang, Y., Liu, Y.-W., & Yeh, M.-L. (2022) · Biomedicines · doi:10.3390/biomedicines10112764 · Cited by 6
Thomas, D., Yang, P. C.-M., Wu, J. C., & Sayed, N. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.09.008 · Cited by 6
Self-citationTatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867 · Cited by 6
Self-citationCampbell, K. A., Terzic, A., & Nelson, T. J. (2015) · Regenerative Medicine · doi:10.2217/rme.15.41 · Cited by 5
Martewicz, S., Magnussen, M., & Elvassore, N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00384 · Cited by 5
Human pluripotent stem cell–based cardiovascular disease modeling and drug discovery
Liu, G., Liu, Z., & Cao, N. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02542-1 · Cited by 5
Generation and Maturation of Human iPSC-derived Cardiac Organoids in Long Term CulturePreprint
Ergir, E., Cruz, J. O. L., Fernandes, S., Cassani, M., Niro, F., Pereira-Sousa, D., Vrbský, J., Vinarský, V., Perestrelo, A. R., Debellis, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.07.483273 · Cited by 5
Rawat, N., & Singh, M. K. (2017) · Veterinary World · doi:10.14202/vetworld.2017.640-649 · Cited by 6
Extending Human Induced Pluripotent Stem Cell Technology to Infectious Diseases
Sinnecker, D., Laugwitz, K., & Moretti, A. (2014) · Circulation Research · doi:10.1161/circresaha.114.304786 · Cited by 4
Induced pluripotent stem cells: A new addition to the virologists armamentarium
Kuadkitkan, A., Wikan, N., & Smith, D. R. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.03.009 · Cited by 4
Jenny, R. A., Hirst, C. E., Lim, S. M., Goulburn, A. L., Micallef, S. J., Labonne, T., Kicic, A., Ling, K., Stick, S. M., Ng, E. S., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0274 · Cited by 3
Transformation to Inducible Pluripotent Stem Cells
Kodo, K., Ong, S., & Wu, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00020-5 · Cited by 3
Self-citationSharma, A. (2020) · Science · doi:10.1126/science.aba6111 · Cited by 2
Self-citationMohamed, H. A., Ibrahim, M. M., El‐Mehasseb, I. M., Ramadan, A. E. M., & Shaban, S. Y. (2022) · Applied Organometallic Chemistry · doi:10.1002/aoc.7009 · Cited by 2
Friedman, C. E., Nguyen, Q. H., Lukowski, S. W., Chiu, H. S., Helfer, A., Miklas, J. W., Suo, S., Han, J. J., Osteil, P., Peng, G., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/229294 · Cited by 2
Pei, X., Stienstra, J. T. A. T., Viola, M., Maas, R. G. C., Defourny, K. A. Y., Mul, E. P. J., de Jager, S. C. A., Sluijter, J. P. G., van Kuppeveld, F. J. M., & Hoen, E. N. M. N. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70305 · Cited by 1
Araña, M. C., Lahuerta, R. D., Cortella, L. R. X., Mazzetto, M., Soldera, M., Lasagni, A. F., Cestari, I. N., & Cestari, I. A. (2022) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-70601-2_31 · Cited by 1
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.575991 · Cited by 1
Self-citationTatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Burridge, P. W., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.1 · Cited by 1
Self-citationiPS Cells and Cardiomyopathies
Nakahama, H., & Pasquale, E. D. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-18314-5_6
Hall, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801812-5.00004-4
Cardiac Directed Differentiation Using Small Molecule WNT Modulation at Single-Cell ResolutionPreprint
Friedman, C. E., Nguyen, Q. H., Lukowski, S. W., Helfer, A., Chiu, H. S., Voges, H. K., Suo, S., Han, J. J., Osteil, P., Peng, G., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155757 · Cited by 2
Veronez, D. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.3.2018.tde-27082018-134139
The application of iPSCs to questions in virology
Smith, D. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00008-0
iPSCs for modeling coxsackievirus infection
Belkaya, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00004-3
iPSCs for modeling influenza infection
Amiri, A. Z., & Coombs, K. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00011-0
Induced pluripotent stem cells for modeling Chagas disease
Bozzi, A., & Stevens, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00003-1
Induced pluripotent stem cells for modeling of cardiac arrhythmias
Sayed, Z. R. A., Corli, M., Masurkar, N. D., & Hulot, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00002-3
Induced pluripotent stem cells
Calvert, B. A., Lorenzana, Z., Senger, C. N., Hsu, C.-Y., Busch, S. M., Koç-Günel, S., Quiroz, E. J., & Ryan, A. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00003-5
Mason, J. W., & Schultheiß, H. (2020) · doi:10.1093/med/9780198746690.003.0353
Circulation Research “In This Issue” Anthology
Williams, R. A., & Editors, T. (2015) · Circulation Research · doi:10.1161/res.0000000000000088
Rossler, K. J., de Lange, W. J., Mann, M. W., Aballo, T. J., Melby, J. A., Zhang, J., Kim, G., Bayne, E. F., Zhu, Y., Farrell, E. T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.05.539642
Stem Cell and its Applications in Medical Biotechnology
Rani, M., Sweeti, Spikey, Kaushik, P., Deepak, S., & Gahalayan, A. (2024) · UTTAR PRADESH JOURNAL OF ZOOLOGY · doi:10.56557/upjoz/2024/v45i84008
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.2
Self-citationTatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Lyra‐Leite, D. M., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.3
Self-citationHeart-Derived Stromal Cells and In Vitro 3D Models in Cardiotoxicity Assessment
Sun, D., & Thankam, F. G. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_31
Kamal, N. H., Saber, F. R., Salama, A., Abouhussein, D. M. N., Ismail, S., El-Hefnawy, H. M., & Meselhy, M. R. (2024) · Figshare · doi:10.6084/m9.figshare.26787034
Lautz, A. J., Kapcar, C. S., Zhang, S., Dunwoodie, L., Harmon, K., Mayhew, C. N., Atreya, M. R., Zingarelli, B., & Genomics of Pediatric Septic Shock Investigators (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.21.695853
3C suppresses PINK1-mediated mitophagy and contributes to coxsackievirus B3 replication
Liu, T., Wan, A., Xu, Y., Lu, H., Xie, Y., Wu, H., Wang, J., Wang, H., Hao, T., Zhang, Y., et al. (2026) · Virulence · doi:10.1080/21505594.2026.2662767
Self-citationSonousi, A. S. M., Mohamed, N., Abdelraheem, O. M., Ibrahim, O., & Ziko, L. (2026) · RSC Advances · doi:10.1039/d6ra04813g
Metadata
- Authors
- Sharma, A., Marceau, C., Hamaguchi, R., Burridge, P. W., Rajarajan, K., Churko, J. M., Wu, H., Sallam, K. I., Matsa, E., Sturzu, A. C., Che, Y., Ebert, A., Diecke, S., Liang, P., Red-Horse, K., Carette, J. E., Wu, S. M., & Wu, J. C.
- Affiliations
- Institute for Stem Cell Biology and Regenerative Medicine (IN)
- From the Department of Medicine, Division of Cardiology (A.S., R.H., P.W.B., K.R., J.M.C., H.W., K.I.S., E.M., A.C.S., Y.C., A.E., S.D., P.L., S.M.W., J.C.W.), Institute for Stem Cell Biology and Regenerative Medicine (A.S., R.H., P.W.B., K.R., J.M.C., H.W., K.I.S., E.M., A.C.S., Y.C., A.E., S.D., P.L., S.M.W., J.C.W.), Stanford Cardiovascular Institute (A.S., R.H., P.W.B., K.R., J.M.C., H.W., K.I.S., E.M., A.C.S., Y.C., A.E., S.D., P.L., K.R.-H., S.M.W., J.C.W.), Department of Biology (A.S., R.H.,...
- ORCID
- Venue
- Circulation Research
- Published
- 2014-08-29
- Volume
- 115
- Issue
- 6
- Pages
- 556-566
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC4149868
- OpenAlex
- W1998190377
- Cited by
- 148
- References
- 50
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 14 · 2023: 8 · 2022: 17 · 2021: 19 · 2020: 14 · 2019: 8 · 2018: 16 · 2017: 12 · 2016: 12 · 2015: 18 · 2014: 2
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Institutes of Health (DP2OD004411, NS069375)
- National Heart, Lung, and Blood Institute (U01HL099776, T32HL007208, R01HL113006)
- National Institute of Allergy and Infectious Diseases (DP2AI104557, T32AI007328)
- National Institute of Neurological Disorders and Stroke (NS069375, P30NS069375)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- coxsackievirus B3, viral myocarditis, human induced pluripotent stem cell-derived cardiomyocytes, antiviral drug screening, interferon-beta, ribavirin, pyrrolidine dithiocarbamate, fluoxetine, coxsackievirus and adenovirus receptor, calcium handling, viral RNA clearance, high-throughput screening, in vitro disease model
- MeSH terms
- Antiviral Agents, Calcium, Cells, Cultured, Drug Evaluation, Preclinical, Enterovirus Infections, Humans, Models, Cardiovascular, Myocarditis, RNA, Viral, Treatment Outcome, Enterovirus B, Human, Myocytes, Cardiac, Pluripotent Stem Cells, Cell Proliferation, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
